Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a Spanish observational study

dc.contributor.author	Salinas Hernández, Pedro
dc.contributor.author	Trujillo Vilchez, Rafael
dc.contributor.author	Arriví García-Ramos, Antonio
dc.contributor.author	Viéitez de Prado, José María
dc.date.accessioned	2015-08-31T10:03:42Z
dc.date.available	2015-08-31T10:03:42Z
dc.date.issued	2013
dc.identifier.citation	Journal of Analytical Oncology, 2(3), p. 128-134 (2013)
dc.identifier.issn	1927-7229
dc.identifier.uri	http://hdl.handle.net/10651/32954
dc.description.statementofresponsibility	Hernández, P.S., Vilchez, R.T., García-Ramos, A.A., de Guevara, R.G.L., Jaraiz, A.R., Moreira, P.G., de Prado, J.M.V., de Tejada, M.R.L., Medina, A.I., Cervera, J.M.C., Vicario, J.C.C., Sarmiento, U.B., Tendero, P.L., Lajara, J.D.A., Carbonero, A.L., García de Paredes, M.G., de Alvaro Liaño, J., Marroquí, A.J., Gómez, L.L., de Prado Otero, D.S.
dc.format.extent	p. 128-134
dc.language.iso	eng
dc.relation.ispartof	Journal of Analytical Oncology
dc.rights	©,
dc.source	Scopus
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-84904917595&partnerID=40&md5=6fb8134b808bdcbcae4cd082d0cf051b
dc.title	Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a Spanish observational study
dc.type	journal article
dc.identifier.local	20142220

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.